gossypol has been researched along with N-[4-(2-tert-butylphenyl)sulfonylphenyl]-2,3,4-trihydroxy-5-[(2-propan-2-ylphenyl)methyl]benzamide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abaan, HO; Gao, W; Guo, J; Jiang, S; Krajewski, K; Meagher, J; Nikolovska-Coleska, Z; Qiu, S; Roller, PP; Shangary, S; Stuckey, J; Tang, G; Tomita, Y; Wang, G; Wang, R; Wang, S; Yang, CY; Yang, D | 1 |
Barelier, S; Krimm, I; Lancelin, JM; Marcillat, O; Pons, J | 1 |
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
3 other study(ies) available for gossypol and N-[4-(2-tert-butylphenyl)sulfonylphenyl]-2,3,4-trihydroxy-5-[(2-propan-2-ylphenyl)methyl]benzamide
Article | Year |
---|---|
Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.
Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Gossypol; Humans; Models, Molecular; Proto-Oncogene Proteins c-bcl-2; Stereoisomerism; Structure-Activity Relationship; Sulfones | 2006 |
Fragment-based deconstruction of Bcl-xL inhibitors.
Topics: bcl-X Protein; Binding Sites; Binding, Competitive; Drug Design; Humans; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Molecular Weight; Organic Chemicals; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship | 2010 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |